Inflammatory bone loss in experimental periodontitis induced by aggregatibacter actinomycetemcomitans in interleukin-1 receptor antagonist knockout mice

Infection and Immunity

Volumn 82, Issue 5, 2014, Pages 1904-1913

  Izawa, A ^a   Ishihara, Y ^a   Mizutani, H ^a   Kobayashi, S ^a   Goto, H ^a   Okabe, E ^a   Takeda, H ^a   Ozawa, Y ^a   Kamiya, Y ^a   Sugita, Y ^a   Kubo, K ^a   Kamei, H ^a   Kikuchi, T ^a   Mitani, A ^a   Hayashi, J ^a   Nishihara, T ^b   Maeda, H ^a   Noguchi, T ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

^b KYUSHU DENTAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; BONE SIALOPROTEIN; COLONY STIMULATING FACTOR 1; CYTOKINE; EOSIN; HEMATOXYLIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; MESSENGER RNA; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN; TRANSCRIPTION FACTOR RUNX2; TUMOR NECROSIS FACTOR ALPHA;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ALVEOLAR BONE; ALVEOLAR BONE LOSS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; CALCIFICATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EXPERIMENTAL INFECTION; EXPERIMENTAL PERIODONTITIS; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; PERIODONTITIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TISSUE SECTION; WILD TYPE;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANIMALS; BONE DISEASES, METABOLIC; BONE RESORPTION; GENE EXPRESSION REGULATION; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MICE, KNOCKOUT; OSTEOPROTEGERIN; PASTEURELLACEAE INFECTIONS; PERIODONTITIS; RANK LIGAND;

EID: 84898836679     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01618-13     Document Type: Article

References (63)

1. Zijnge V, Ammann T, Thurnheer T, Gmur R. 2012. Subgingival biofilm structure. Front. Oral Biol. 15:1-16. http://dx.doi.org/10.1159/000329667.
2. Teles RP, Gursky LC, Faveri M, Rosa EA, Teles FR, Feres M, Socransky SS, Haffajee AD. 2010. Relationships between subgingival microbiota and GCFbiomarkers in generalized aggressive periodontitis. J. Clin. Periodontol. 37:313-323. http://dx.doi.org/10.1111/j.1600-051X.2010.01534.x.
3. Heitz-Mayfield LJ. 2005. Disease progression: identification of high-risk groups and individuals for periodontitis. J. Clin. Periodontol. 32(Suppl 6):196-209. http://dx.doi.org/10.1111/j.1600-051X.2005.00803.x.
4. Kinane DF, Peterson M, Stathopoulou PG. 2006. Environmental and other modifying factors of the periodontal diseases. Periodontol. 2000 40:107-119. http://dx.doi.org/10.1111/j.1600-0757.2005.00136.x.
5. Beck JD. 1994. Methods of assessing risk for periodontitis and developing multifactorial models. J. Periodontol. 65:468-478. http://dx.doi.org/10.1902/jop.1994.65.5s.468.
6. Wilson M, Henderson B. 1995. Virulence factors of Actinobacillus actinomycetemcomitans relevant to the pathogenesis of inflammatory periodontal diseases. FEMS Microbiol. Rev. 17:365-379. http://dx.doi.org/10.1111/j.1574-6976.1995.tb00220.x.
7. Tsutsumi T, Nakashima K, Isoda T, Yokota M, Nishihara T. 2010. Involvement of adhesion molecule in in vitro plaque-like formation of macrophages stimulated with Aggregatibacter actinomycetemcomitans lipopolysaccharide. J. Periodontal Res. 45:550-556. http://dx.doi.org/10.1111/j.1600-0765.2010.01270.x.
8. Nakashima K, Schenkein HA, Califano JV, Tew JG. 1997. Heterogeneity of antibodies reactive with the dominant antigen of Actinobacillus actinomycetemcomitans. Infect. Immun. 65:3794-3798.
9. Takahashi T, Nishihara T, Ishihara Y, Amano K, Shibuya N, Moro I, Koga T. 1991. Murine macrophage interleukin-1 release by capsularlike serotype-specific polysaccharide antigens of Actinobacillus actinomycetemcomitans. Infect. Immun. 59:18-23.
10. Gunsolley JC, Burmeister JA, Tew JG, Best AM, Ranney RR. 1987. Relationship of serum antibody to attachment level patterns in young adults with juvenile periodontitis or generalized severe periodontitis. J. Periodontol. 58:314-320. http://dx.doi.org/10.1902/jop.1987.58.5.314.
11. Diehl SR, Wang Y, Brooks CN, Burmeister JA, Califano JV, Wang S, Schenkein HA. 1999. Linkage disequilibrium of interleukin-1 genetic polymorphisms with early-onset periodontitis. J. Periodontol. 70:418-430. http://dx.doi.org/10.1902/jop.1999.70.4.418.
12. Parkhill JM, Hennig BJ, Chapple IL, Heasman PA, Taylor JJ. 2000. Association of interleukin-1 gene polymorphisms with early-onset periodontitis. J. Clin. Periodontol. 27:682-689. http://dx.doi.org/10.1034/j.1600-051x.2000.027009682.x.
13. Ishihara Y, Nishihara T, Maki E, Noguchi T, Koga T. 1991. Role of interleukin-1 and prostaglandin in in vitro bone resorption induced by Actinobacillus actinomycetemcomitans lipopolysaccharide. J. Periodontal Res. 26:155-160. http://dx.doi.org/10.1111/j.1600-0765.1991.tb01639.x.
14. Nishihara T, Ueda N, Amano K, Ishihara Y, Hayakawa H, Kuroyanagi T, Ohsaki Y, Nagata K, Noguchi T. 1995. Actinobacillus actinomycetemcomitans Y4 capsular-polysaccharide-like polysaccharide promotes osteoclast-like cell formation by interleukin-1α production in mouse marrow cultures. Infect. Immun. 63:1893-1898.
15. Ueda N, Koide M, Ohguchi M, Ishihara Y, Noguchi T, Okahashi N, Nishihara T. 1998. Involvement of prostaglandin E2 and interleukin-1α in the differentiation and survival of osteoclasts induced by lipopolysaccharide from Actinobacillus actinomycetemcomitans Y4. J. Periodontal Res. 33:509-516.
16. Ohguchi Y, Ishihara Y, Ohguchi M, Koide M, Shirozu N, Naganawa T, Nishihara T, Noguchi T. 2003. Capsular polysaccharide from Actinobacillus actinomycetemcomitans inhibits IL-6 and IL-8 production in human gingival fibroblast. J. Periodontal Res. 38:191-197. http://dx.doi.org/10.1034/j.1600-0765.2003.00656.x.
17. Kesavalu L, Chandrasekar B, Ebersole JL. 2002. In vivo induction of proinflammatory cytokines in mouse tissue by Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans. Oral Microbiol. Immunol. 17: 177-180. http://dx.doi.org/10.1034/j.1399-302X.2002.170307.x.
18. Ishihara Y, Nishihara T, Kuroyanagi T, Shirozu N, Yamagishi E, Ohguchi M, Koide M, Ueda N, Amano K, Noguchi T. 1997. Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites. J. Periodontal Res. 32:524-529. http://dx.doi.org/10.1111/j.1600-0765.1997.tb00568.x.
19. Toker H, Poyraz O, Eren K. 2008. Effect of periodontal treatment on IL-1β, IL-1ra, and IL-10 levels in gingival crevicular fluid in patients with aggressive periodontitis. J. Clin. Periodontol. 35:507-513. http://dx.doi.org/10.1111/j.1600-051X.2008.01213.x.
20. Sawada S, Chosa N, Ishisaki A, Naruishi K. 2013. Enhancement of gingival inflammation induced by synergism of IL-1β and IL-6. Biomed. Res. 34:31-40. http://dx.doi.org/10.2220/biomedres.34.31.
21. Havemose-Poulsen A, Sorensen LK, Stoltze K, Bendtzen K, Holmstrup P. 2005. Cytokine profiles in peripheral blood and whole blood cell cultures associated with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis. J. Periodontol. 76:2276-2285. http://dx.doi.org /10.1902/jop.2005.76.12.2276.
22. Mizutani H, Ishihara Y, Izawa A, Fujihara Y, Kobayashi S, Gotou H, Okabe E, Takeda H, Ozawa Y, Kamiya Y, Kamei H, Kikuchi T, Yamamoto G, Mitani A, Nishihara T, Noguchi T. 2013. Lipopolysaccharide of Aggregatibacter actinomycetemcomitans up-regulates inflammatory cytokines, prostaglandin E synthesis and osteoclast formation in interleukin-1 receptor antagonist-deficient mice. J. Periodontal Res. 48: 748-756. http://dx.doi.org/10.1111/jre.12065.
23. Jimi E, Nakamura I, Duong LT, Ikebe T, Takahashi N, Rodan GA, Suda T. 1999. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp. Cell Res. 247:84-93. http://dx.doi.org/10.1006/excr.1998.4320.
24. Kimble RB, Vannice JL, Bloedow DC, Thompson RC, Hopfer W, Kung VT, Brownfield C, Pacifici R. 1994. Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. J. Clin. Invest. 93:1959-1967. http://dx.doi.org/10.1172/JCI117187.
25. Horai R, Asano M, Sudo K, Kanuka H, Suzuki M, Nishihara M, Takahashi M, Iwakura Y. 1998. Production of mice deficient in genes for interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 receptor antagonist shows that IL-1β is crucial in turpentine-induced fever development and glucocorticoid secretion. J. Exp. Med. 187:1463-1475. http://dx.doi.org/10.1084/jem.187.9.1463.
26. Yamano R, Ohara M, Nishikubo S, Fujiwara T, Kawamoto T, Ueno Y, Komatsuzawa H, Okuda K, Kurihara H, Suginaka H, Oswald E, Tanne K, Sugai M. 2003. Prevalence of cytolethal distending toxin production in periodontopathogenic bacteria. J. Clin. Microbiol. 41:1391-1398. http: //dx.doi.org/10.1128/JCM.41.4.1391-1398.2003.
27. Stathopoulou PG, Benakanakere MR, Galicia JC, Kinane DF. 2010. Epithelial cell pro-inflammatory cytokine response differs across dental plaque bacterial species. J. Clin. Periodontol. 37:24-29. http://dx.doi.org /10.1111/j.1600-051X.2009.01505.x.
28. Baker PJ, Evans RT, Roopenian DC. 1994. Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. Arch. Oral Biol. 39:1035-1040. http://dx.doi.org/10.1016/0003-9969(94)90055-8.
29. Rennard SI, Kimata K, Dusemund B, Barrach HJ, Wilczek J, Kimura JH, Hascall VC. 1981. An enzyme-linked immunoassay for the cartilage proteoglycan. Arch. Biochem. Biophys. 207:399-406. http://dx.doi.org /10.1016/0003-9861(81)90047-3.
30. Amano K, Nishihara T, Shibuya N, Noguchi T, Koga T. 1989. Immunochemical and structural characterization of a serotype-specific polysaccharide antigen from Actinobacillus actinomycetemcomitans Y4 (serotype b). Infect. Immun. 57:2942-2946.
31. Wilensky A, Polak D, Awawdi S, Halabi A, Shapira L, Houri-Haddad Y.2009. Strain-dependent activation of the mouse immune response is correlated with Porphyromonas gingivalis-induced experimental periodontitis. J. Clin. Periodontol. 36:915-921. http://dx.doi.org/10.1111/j.1600-051X.2009.01464.x.
32. Doty SL, Lopatin DE, Syed SA, Smith FN. 1982. Humoral immune response to oral microorganisms in periodontitis. Infect. Immun. 37:499-505.
33. Nishikawa T, Naruse K, Kobayashi Y, Miyajima S, Mizutani M, Kikuchi T, Soboku K, Nakamura N, Sokabe A, Tosaki T, Hata M, Ohno N, Noguchi T, Matsubara T. 2012. Involvement of nitrosative stress in experimental periodontitis in diabetic rats. J. Clin. Periodontol. 39:342-349. http://dx.doi.org/10.1111/j.1600-051X.2011.01848.x.
34. Park CH, Abramson ZR, Taba M, Jr, Jin Q, Chang J, Kreider JM, Goldstein SA, Giannobile WV. 2007. Three-dimensional microcomputed tomographic imaging of alveolar bone in experimental bone loss or repair. J. Periodontol. 78:273-281. http://dx.doi.org/10.1902/jop.2007.060252.
35. Claudino M, Garlet TP, Cardoso CR, de Assis GF, Taga R, Cunha FQ, Silva JS, Garlet GP. 2010. Down-regulation of expression of osteoblast and osteocyte markers in periodontal tissues associated with the spontaneous alveolar bone loss of interleukin-10 knockout mice. Eur. J. Oral Sci. 118:19-28. http://dx.doi.org/10.1111/j.1600-0722.2009.00706.x.
36. Goya JA, Paez HA, Mandalunis PM. 2006. Effect of topical administration of monosodium olpadronate on experimental periodontitis in rats. J. Periodontol. 77:1-6. http://dx.doi.org/10.1902/jop.2006.77.1.1.
37. Lima HR, Gelani V, Fernandes AP, Gasparoto TH, Torres SA, Santos CF, Garlet GP, da Silva JS, Campanelli AP. 2010. The essential role of toll like receptor-4 in the control of Aggregatibacter actinomycetemcomitans infection in mice. J. Clin. Periodontol. 37:248-254. http://dx.doi.org/10.1111/j.1600-051X.2009.01531.x.
38. Kondo M, Kondo H, Miyazawa K, Goto S, Togari A. 2013. Experimental tooth movement-induced osteoclast activation is regulated by sympathetic signaling. Bone 52:39-47. http://dx.doi.org/10.1016/j.bone.2012.09.007.
39. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR. 1987. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2:595-610.
40. Suda T, Jimi E, Nakamura I, Takahashi N. 1997. Role of 1α,25-dihydroxyvitaminD3 in osteoclast differentiation and function. Methods Enzymol. 282:223-235. http://dx.doi.org/10.1016/S0076-6879(97)82110-6.
41. Ohno T, Okahashi N, Morisaki I, Amano A. 2008. Signaling pathways in osteoblast proinflammatory responses to infection by Porphyromonas gingivalis. Oral Microbiol. Immunol. 23:96-104. http://dx.doi.org/10.1111/j.1399-302X.2007.00393.x.
42. Amar S, Wu SC, Madan M. 2009. Is Porphyromonas gingivalis cell invasion required for atherogenesis? Pharmacotherapeutic implications. J. Immunol. 182:1584-1592.
43. Wilensky A, Gabet Y, Yumoto H, Houri-Haddad Y, Shapira L. 2005. Three-dimensional quantification of alveolar bone loss in Porphyromonas gingivalis-infected mice using micro-computed tomography. J. Periodontol. 76:1282-1286. http://dx.doi.org/10.1902/jop.2005.76.8.1282.
44. Baker PJ, Dixon M, Roopenian DC. 2000. Genetic control of susceptibility to Porphyromonas gingivalis-induced alveolar bone loss in mice. Infect. Immun. 68:5864-5868. http://dx.doi.org/10.1128/IAI.68.10.5864 -5868.2000.
45. Sasaki H, Okamatsu Y, Kawai T, Kent R, Taubman M, Stashenko P. 2004. The interleukin-10 knockout mouse is highly susceptible to Porphyromonas gingivalis-induced alveolar bone loss. J. Periodontal Res. 39:432-441. http://dx.doi.org/10.1111/j.1600-0765.2004.00760.x.
46. Kang J, de Brito Bezerra B, Pacios S, Andriankaja O, Li Y, Tsiagbe V, Schreiner H, Fine DH, Graves DT. 2012. Aggregatibacter actinomycetemcomitans infection enhances apoptosis in vivo through a caspase-3-dependent mechanism in experimental periodontitis. Infect. Immun. 80: 2247-2256. http://dx.doi.org/10.1128/IAI.06371-11.
47. Baker PJ, DuFour L, Dixon M, Roopenian DC. 2000. Adhesion molecule deficiencies increase Porphyromonas gingivalis-induced alveolar bone loss in mice. Infect. Immun. 68:3103-3107. http://dx.doi.org/10.1128/IAI.68.6.3103-3107.2000.
48. Niederman R, Westernoff T, Lee C, Mark LL, Kawashima N, Ullman-Culler M, Dewhirst FE, Paster BJ, Wagner DD, Mayadas T, Hynes RO, Stashenko P. 2001. Infection-mediated early-onset periodontal disease in P/E-selectin-deficient mice. J. Clin. Periodontol. 28:569-575. http://dx.doi.org/10.1034/j.1600-051x.2001.028006569.x.
49. Kawashima N, Niederman R, Hynes RO, Ullmann-Cullere M, Stashenko P. 1999. Infection-stimulated infraosseus inflammation and bone destruction is increased in P-/E-selectin knockout mice. Immunology 97: 117-123. http://dx.doi.org/10.1046/j.1365-2567.1999.00754.x.
50. Cassatella MA, Meda L, Gasperini S, Calzetti F, Bonora S. 1994. Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J. Exp. Med. 179:1695-1699. http://dx.doi.org/10.1084/jem.179.5.1695.
51. Marie C, Pitton C, Fitting C, Cavaillon JM. 1996. IL-10 and IL-4 synergize with TNF-α to induce IL-1ra production by human neutrophils. Cytokine 8:147-151. http://dx.doi.org/10.1006/cyto.1996.0021.
52. Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A, Ikuse T, Asano M, Iwakura Y. 2000. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J. Exp. Med. 191:313-320. http://dx.doi.org/10.1084/jem.191.2.313.
53. Nakae S, Asano M, Horai R, Sakaguchi N, Iwakura Y. 2001. IL-1 enhances T cell-dependent antibody production through induction of CD40 ligand and OX40 on T cells. J. Immunol. 167:90-97.
54. Ishihara Y, Zhang JB, Fakher M, Best AM, Schenkein HA, Barbour SE, Tew JG. 2001. Non-redundant roles for interleukin-1α and interleukin-1α in regulating human IgG2. J. Periodontol. 72:1332-1339. http://dx.doi.org/10.1902/jop.2001.72.10.1332.
55. Li J, Sarosi I, Yan XQ, Morony S, Capparelli C, Tan HL, McCabe S, Elliott R, Scully S, Van G, Kaufman S, Juan SC, Sun Y, Tarpley J, Martin L, Christensen K, McCabe J, Kostenuik P, Hsu H, Fletcher F, Dunstan CR, Lacey DL, Boyle WJ. 2000. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc. Natl. Acad. Sci. U. S. A. 97:1566-1571. http://dx.doi.org/10.1073/pnas.97.4.1566.
56. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L. 1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175-179. http://dx.doi.org/10.1038 /36593.
57. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176. http://dx.doi.org/10.1016/S0092-8674(00)81569-X.
58. Takahashi N, Udagawa N, Akatsu T, Tanaka H, Shionome M, Suda T. 1991. Role of colony-stimulating factors in osteoclast development. J. Bone Miner. Res. 6:977-985.
59. Corboz VA, Cecchini MG, Felix R, Fleisch H, van der Pluijm G, Lowik CW. 1992. Effect of macrophage colony-stimulating factor on in vitro osteoclast generation and bone resorption. Endocrinology 130:437-442. http://dx.doi.org/10.1210/endo.130.1.1727717.
60. Schett G, Redlich K, Hayer S, Zwerina J, Bolon B, Dunstan C, Gortz B, Schulz A, Bergmeister H, Kollias G, Steiner G, Smolen JS. 2003. Osteoprotegerin protects against generalized bone loss in tumor necrosis factortransgenic mice. Arthritis Rheum. 48:2042-2051. http://dx.doi.org/10.1002/art.11150.
61. Hughes FJ, Turner W, Belibasakis G, Martuscelli G. 2006. Effects of growth factors and cytokines on osteoblast differentiation. Periodontol. 2000 41:48-72. http://dx.doi.org/10.1111/j.1600-0757.2006.00161.x.
62. Ishibe T, Kimura A, Ishida Y, Takayasu T, Hayashi T, Tsuneyama K, Matsushima K, Sakata I, Mukaida N, Kondo T. 2009. Reduced acetaminophen-induced liver injury in mice by genetic disruption of IL-1 receptor antagonist. Lab. Invest. 89:68-79. http://dx.doi.org/10.1038 /labinvest.2008.110.
63. Tanabe N, Ito-Kato E, Suzuki N, Nakayama A, Ogiso B, Maeno M, Ito K. 2004. IL-1α affects mineralized nodule formation by rat osteoblasts. Life Sci. 75:2317-2327. http://dx.doi.org/10.1016/j.lfs.2004.04.026.